Search

everythinglearnresearchcommunity

for

Search:↓

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Polyamidoamine dendrimers can change the strength and direction of electroosmotic flow through the skin, affecting drug delivery.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Mycophenolic acid may help treat hair loss by promoting hair growth and cell proliferation.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Detachable microneedles with chitin derivatives effectively promote hair regrowth in androgenic alopecia without toxicity.

The MXD/24HA salt is more effective for hair growth than raw MXD.

Nanocarriers make melatonin more effective and reduce side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Rats had lasting erectile problems after stopping a certain medication.

A new peptide delivered through microneedles can effectively promote hair regrowth.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Allopregnanolone likely doesn't influence ethanol's rewarding effects in these mice.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.